Agios Pharmaceuticals, Inc. (AGIO)

Last Three Months

19-Jan-24 -- 18-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Sell

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

27

0

6

+1

0

+2

0

+3

Two Year Chart

19-Apr-22 -- 18-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
11-Mar-24 4:09 PM View:	07-Mar-24 Sale ($40.63K)	Foster-Cheek Kaye I Director		Agios Pharmaceuticals, Inc. - AGIO	(44%) 13.72K to 7.72K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 4:05 PM View:	27-Feb-24 Option Sale ($2.40M)	Schenkein David P Director		Agios Pharmaceuticals, Inc. - AGIO	0% 472.71K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:20 PM View:	05-Mar-24 Planned Option Sale ($86.05K)	Gheuens Sarah Chief Medical Officer		Agios Pharmaceuticals, Inc. - AGIO	40% 27.87K to 39.07K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:08 PM View:	05-Mar-24 Planned Option Sale ($86.05K)	Burns James William Chief Legal Officer		Agios Pharmaceuticals, Inc. - AGIO	41% 26.34K to 37.17K	0	0	--	--	Show Txns Hide Txns

07-Mar-24 6:47 PM View:	05-Mar-24 Sale ($60.74K)	Washburn Theodore James Jr. Principal Accounting Officer		Agios Pharmaceuticals, Inc. - AGIO	5% 2.74K to 2.89K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:10 PM View:	05-Mar-24 Planned Option Sale ($135.36K)	Goff Brian Chief Executive Officer Director		Agios Pharmaceuticals, Inc. - AGIO	34% 40.05K to 53.78K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:18 PM View:	05-Mar-24 Planned Option Sale ($21.89K)	Jones Cecilia Chief Financial Officer		Agios Pharmaceuticals, Inc. - AGIO	55% 9.57K to 14.84K	0	0	--	--	Show Txns Hide Txns

24-Jan-24 4:19 PM View:	24-Jan-24 Planned Option Sale ($35.01K)	Milanova Tsveta Chief Commercial Officer		Agios Pharmaceuticals, Inc. - AGIO	41% 9.4K to 13.23K	0	0	--	--	Show Txns Hide Txns

10-Apr-24 4:03 PM View:	10-Apr-24 Planned Option Sale ($214.64K)	Fouse Jacqualyn A Director		Agios Pharmaceuticals, Inc. - AGIO	18% 116.08K to 137.4K	0	0	--	--	Show Txns Hide Txns